JLR will supercharge next-generation vehicle connectivity with Tata Communications MOVE™ Drivers to remain connected from the remotest locations in 120 countries, with real-time vehicle location services, smarter driving experiences and increased software over-the-air (SOTA) updatesPartnership is part of JLR’s wider innovation strategy to establish universal connectivity for its vehicles and deliver continuously evolving AI-driven digital features and services for its customers

MUMBAI, India, Jan. 16, 2025 /PRNewswire/ — JLR and Tata Communications are set to enhance JLR’s connected vehicle ecosystem, transforming the driving experience for customers worldwide through the Tata Communications MOVE™ platform. The collaboration will empower JLR’s next-generation software-defined vehicles with continuous connectivity and access to intelligent services even in the remotest locations across 120 countries. The latest collaboration is an extension of their existing partnership to future-proof the carmaker’s digital transformation.

Leveraging Tata Communications MOVE™ platform, JLR’s upcoming medium-sized SUVs built on the new Electric Modular Architecture (EMA) will seamlessly transition between mobile networks and operators, enabling non-stop access to personalised connected services, such as media streaming. The platform will also enable greater and more secure data exchange between JLR and its customers’ vehicles, delivering more efficient software over-the-air (SOTA) updates and supporting the rollout of evolving advanced driver assistance systems (ADAS).

Every day, JLR’s fleet of connected vehicles generates 2.5 terabytes (TB) of data, with half a million electronic control units (ECUs) updated per month on average over the last 12 months. The use of Tata Communications MOVE™ platform will increase this data exchange and enable JLR engineers to harness deeper insights, monitor vehicle performance in real-time, and enable more prompt updates over the air to improve vehicle maintenance and servicing, reducing costs for the car owners and JLR.

The advanced vehicles, expected to hit the roads in 2026, will deliver a smarter and more intelligent driving experience.

The introduction of the Tata Communications MOVE™ will offer JLR customers:

Resilient wireless communication technologies to help track vehicles in the most demanding environmentsIncreased and more frequent vehicle software updates delivered over the air to improve vehicle diagnostics and updatesTailored connections will keep customers and their families connected to their preferred applications and vehicle features, wherever they are in the worldSimplified and effortless connectivity plans, accessible via a single provider

Marco Bijvelds, Vice President and Global Head of Tata Communications MOVE™, said: “The automotive industry is continually innovating to meet ever-changing customer demands. Last year, our digital fabric enabled seamless connectivity across all JLR’s production sites globally. As part of our extended partnership, we’re now powering JLR’s software-defined vehicle journey worldwide and enabling them to deliver advanced driving features in their cars. The insights derived from the data exchanged through our platform will enable JLR to offer personalised customer experiences, opening doors for new revenue streams.”

Mark Brogden, Director of Digital Product Platform Off-Board at JLR, said: “JLR was the first luxury vehicle manufacturer to introduce dual modem, dual eSIM design for enhanced connectivity with the launch of Defender in 2020. The partnership with Tata Communications is the next step in our software-defined vehicle journey, offering highly secure and cost-effective data connectivity across 120 countries. Starting in 2026 with our next generation of medium-size luxury SUVs, Tata Communications MOVE™ aims to deliver continuous connected experiences for our clients, offering features and new software updates over-the-air to meet the expectations of our luxury client base.” 

Tata Communications Media Contacts :
Judhajit Basu
judhajit.basu@tatacommunications.com   

Aastha Singh
aastha.singh2@tatacommunications.com

JLR Media Contacts :
David Wrottesley
dwrottes@jaguarlandrover.com  

Francis Robertson Marriott
frobert4@jaguarlandrover.com 

About JLR

JLR’s Reimagine strategy is delivering a sustainability-rich vision of modern luxury by design. 

We are transforming our business with the aim to become carbon net zero across our supply chain, products, and operations by 2039. We have set a roadmap to reduce emissions across our own operations and value chains by 2030 through approved, science-based targets. Electrification is central to this strategy and before the end of the decade our Range Rover, Discovery, Defender collections will each have a pure electric model, while Jaguar will be entirely electric. 

At heart we are a British company, with two design and engineering sites, three vehicle manufacturing facilities, an engine manufacturing centre, and a battery assembly centre in the UK. We also have vehicle plants in China (joint venture), Slovakia, India, and Brazil, as well as seven technology hubs across the globe. JLR is a wholly owned subsidiary of Tata Motors Limited, part of Tata Sons.

About Tata Communications

A part of the Tata Group, Tata Communications (NSE: TATACOMM) (BSE: 500483) is a global digital ecosystem enabler powering today’s fast-growing digital economy in more than 190 countries and territories. Leading with trust, it enables digital transformation of enterprises globally with collaboration and connected solutions, core and next gen connectivity, cloud hosting and security solutions and media services. 300 of the Fortune 500 companies are its customers and the company connects businesses to 80% of the world’s cloud giants. For more information, please visit www.tatacommunications.com 

Forward-looking and cautionary statements

Certain words and statements in this release concerning Tata Communications and its prospects, and other statements, including those relating to Tata Communications’ expected financial position, business strategy, the future development of Tata Communications’ operations, and the general economy in India, are forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors, including financial, regulatory and environmental, as well as those relating to industry growth and trend projections, which may cause actual results, performance or achievements of Tata Communications, or industry results, to differ materially from those expressed or implied by such forward-looking statements. The important factors that could cause actual results, performance or achievements to differ materially from such forward-looking statements include, among others, failure to increase the volume of traffic on Tata Communications’ network; failure to develop new products and services that meet customer demands and generate acceptable margins; failure to successfully complete commercial testing of new technology and information systems to support new products and services, including voice transmission services; failure to stabilize or reduce the rate of price compression on certain of the company’s communications services; failure to integrate strategic acquisitions and changes in government policies or regulations of India and, in particular, changes relating to the administration of Tata Communications’ industry; and, in general, the economic, business and credit conditions in India. Additional factors that could cause actual results, performance or achievements to differ materially from such forward-looking statements, many of which are not in Tata Communications’ control, include, but are not limited to, those risk factors discussed in Tata Communications Limited’s Annual Reports. 

The Annual Reports of Tata Communications Limited are available at www.tatacommunications.com. Tata Communications is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements.

© 2025 Tata Communications Ltd. All rights reserved.

TATA COMMUNICATIONS and TATA are trademarks or registered trademarks of Tata Sons Private Limited in India and certain countries.

Photo: https://mma.prnewswire.com/media/2599748/JLR_car.jpg
Logo: https://mma.prnewswire.com/media/2268954/Tata_Communications_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/jlr-and-tata-communications-strengthen-partnership-to-deliver-smarter-data-driven-connected-cars-302352905.html

SOURCE Tata Communications

ABU DHABI, UAE, Jan. 16, 2025 /PRNewswire/ — Sungrow, the global leading PV inverter and energy storage system provider, made a remarkable start to the year at the World Future Energy Summit (WFES) 2025 by officially launching the SG150CX, a cutting-edge high-power string inverter tailored for the evolving demands of the commercial and industrial (C&I) market. The product launch took place at Sungrow’s booth (#6220, Hall 6) at the ADNEC Centre, drawing significant attention from stakeholders across the energy industry.

SG150CX: A Game-Changer for C&I Solar Applications

Engineered for exceptional performance, safety, and reliability, the SG150CX brings advanced innovations to large-scale C&I solar applications. Its key innovations include:

High Efficiency: Achieving a remarkable 98.8% inversion efficiency at 400V AC, the SG150CX maximizes energy yield, contributing to lower Levelized Cost of Energy (LCOE).Advanced Safety Features: Equipped with Arc Fault Circuit Interrupter (AFCI) 3.0 technology, it offers an extended cable detection range of up to 450 meters, enhancing operational safety.High Input Current Capacity: Featuring a 48A maximum power point tracking (MPPT) input current, the SG150CX ensures compatibility with High-current PV modules, significantly boosting system efficiency.Smart String-Level Disconnection: Equipped with smart switches, the inverter disconnects faulty strings under the same switch while maintaining others operational, drastically reducing power generation losses.

The Middle East’s commercial and industrial C&I sector is driving demand for advanced solar solutions due to rising energy costs, ambitious clean energy goals, and challenging environmental conditions. Sungrow’s SG150CX addresses these needs with its high-efficiency 48A MPPT input, advanced AFCI technology for enhanced safety, and durable design for harsh climates. By lowering operational costs and supporting decarbonization, the SG150CX offers a reliable solution for businesses aligning with the region’s sustainability initiatives.

Engage with Sungrow at WFES 2025

Sungrow invites stakeholders, partners, and attendees to visit booth #6220 to explore the SG150CX firsthand. On-site experts will provide in-depth insights into the product’s capabilities and discuss integration into future solar projects.

As the renewable energy industry accelerates into 2025, the SG150CX sets a new standard for C&I solar applications, reaffirming Sungrow’s commitment to innovation and bridging to a sustainable future.

About Sungrow

Sungrow, a global leader in renewable energy technology, has pioneered sustainable power solutions for over 28 years. As of June 2024, Sungrow’s power electronic converters have achieved a total installed capacity of 605 GW worldwide. The company is recognized as the world’s No. 1 in PV inverter shipments (S&P Global Commodity Insights) and the most bankable energy storage company (BloombergNEF). Its innovations power clean energy projects in over 180 countries, supported by a network of 520 service outlets guaranteeing excellent customer experience. At Sungrow, we’re committed to building a sustainable future through cutting-edge technology and unmatched service. For more information, please visit www.sungrowpower.com. 

Photo – https://mma.prnewswire.com/media/2598538/SG150CX_Product.jpg
Photo – https://mma.prnewswire.com/media/2598552/image.jpg
Logo – https://mma.prnewswire.com/media/1344575/Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/wfes-2025-sungrow-unveils-next-generation-ci-solar-solutions-bridging-to-a-sustainable-future-in-the-mena-region-302352912.html

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year

LONDON, Jan. 16, 2025 /CNW/ — BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while forecasting key developments for 2025.

As the biopharma and med-tech industries continue to evolve, 2024 proved to be a landmark year. The comprehensive recap by BioWorld highlights therapeutic breakthroughs in psychiatry, oncology, women’s health and infectious diseases, alongside economic highs and lows that challenged the global landscape. The series also examines regulatory changes, including U.S. court cases and international policy shifts, that could shape the future of drug pricing, reimbursement, and innovation.

Lynn Yoffee, Publisher of BioWorld, said: “The 2024 Year in Review series provides a powerful lens into the transformative events and advancements that shaped our industry this year. With our team of expert journalists and analysts, we strive to distill complex developments into actionable insights, empowering stakeholders to make informed decisions as they navigate 2025 and beyond.”

Key Highlights of the BioWorld 2024 Year in Review Series:

BioWorld Year in Review: This section highlights the top mergers and acquisitions, licensing deals, financings, and first approvals of 2024. It also provides insights into key therapeutic trends such as GLP-1 receptor agonists, antibody-drug conjugates (ADCs), psychedelics, and the evolving role of precision psychiatry, alongside innovations spurred by the pandemic. Featured articles include:

The Economy: Top Biopharma Trends of 2024 by Amanda Lanier 
A comprehensive infographic that highlights how 2024 showcased resilience amidst challenges, with biopharma financing and deal values rebounding significantly despite over 18,000 job losses and a tempered IPO market. Spotlights include record-high deal values, a steady M&A pace with reduced total value, and a slightly increased rate of workforce reductions compared to 2023.Year’s top US court cases to present new challenges for 2025 by Mari Serebrov
The Loper Bright decision ended the Chevron doctrine, curbing agency authority and reshaping regulatory dynamics for 2025. Meanwhile, Gilead’s $40 million settlement over HIV drug delays highlights new liability risks for biopharma. Both developments underscore the evolving legal landscape and its potential to reshape regulatory and innovation dynamics in 2025.European VC improves in 2024, driven by ADCs and CNS, inflammatory drugs by Nuala Moran
European biotech funding improved in 2024, with venture capital raised exceeding 2020 levels but still trailing the pandemic peak. Investors favored later-stage programs with clearer paths to exits, while antibody-drug conjugates (ADCs) and central nervous system (CNS) assets drew significant interest. Despite challenges like closed public markets and antimicrobial fragility, optimism for 2025 is growing, fueled by expected macroeconomic improvements and strong M&A activity.GLP-1 receptor agonists continue their global victory tour by Anette Breindl
GLP-1 receptor agonists (GLP-1RAs) had a transformative 2024, expanding into new therapeutic indications, including FDA approval for treating obstructive sleep apnea in adults with obesity, while continuing to demonstrate benefits in cardiovascular health, kidney disease, and other conditions. Despite their success, GLP-1RAs remain treatments rather than cures for underlying conditions like diabetes, prompting ongoing research into root-cause solutions.

BioWorld MedTech Year in Review: This section recaps key med-tech and diagnostic breakthroughs, covering cutting-edge advancements in brain mapping and pregnancy health, as well as regulatory developments expected to impact the sector in 2025. Coverage includes: 

AI drives financings, approvals for APAC med-tech in 2024 By Marian (YoonJee) Chu
In 2024, AI spurred significant financings and approvals in APAC med-tech, leveraging regional strengths like talent pools, data infrastructure, and government support. Key highlights included AI-powered IPOs, billion-dollar pharma collaborations, and national investments, solidifying APAC’s role in AI-driven healthcare innovation.Medicare coverage issues abound in 2024 by Mark McCarty
In 2024, Medicare faced challenges in covering emerging technologies, with the new TCET policy offering limited scope. Coverage for digital health and SaaS remained stalled due to outdated benefit categories. Meanwhile, Medicare’s reimbursement rates for radiation oncology and skin substitutes sparked controversy.

BioWorld Science Year in Review: This section explores key research milestones, featuring global collaborations in infectious diseases, breakthroughs in curable tumors and innovations in women’s health and neuroscience. Key highlights include:

The map for a journey to the center of the brain by Mar de Miguel
The year 2024 marks a milestone with the end of a long journey: a complete cellular map of the fruit fly brain, Drosophila melanogaster, and a cubic millimeter of the human brain. The adventure is just beginning for the thinking species Homo sapiens.Progress in cancer research, even the toughest types by Mar de Miguel and Anette Breindl
Among the most profound results presented at the 2024 European Society for Medical Oncology  Congress were the 10-year data from the Checkmate-067 and Keynote-006 trials, the phase III trials that tested Opdivo (nivolumab, Bristol Myers Squibb Co.) and Keytruda (pembrolizumab, Merck & Co. Inc.) as first-line agents in advanced or metastatic melanoma.

The series also includes the BioWorld editorial picks for the “Best of 2024,” dynamic infographics summarizing key data, and a global perspective on funding and policy changes across Europe and Asia.

To access the full BioWorld special series, visit https://www.bioworld.com/special_reports.  

Join the conversation and mention BioWorld on X and LinkedIn as well as Clarivate for Life Sciences & Healthcare on X and LinkedIn. 

About BioWorld
With writers and editors stationed around the globe, BioWorld published by Clarivate, reports the breaking news – and provides key perspective on thousands of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld has a long tradition of excellence in journalism. Collectively, the news services have been honored with 70 awards dating back to 1998.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.Clarivate.com.

Media Contact:
Catherine Daniel
Director, External Communications, Life Sciences & Healthcare
newsroom@Clarivate.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bioworld-by-clarivate-releases-comprehensive-2024-year-in-review-302352663.html

SOURCE Clarivate Plc